Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Portable Bioprocessing Bioreactors Market by Capacity (110L, 1050L, 50100L, 100500L) and by End User (Biopharmaceuticals Industry, Academic Institute, Research Laboratories): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03849

Pages: NA

Charts: NA

Tables: NA

Portable bioprocessing bioreactors are one of the most widely used devices to simulate a natural biochemical environment for the optimum growth of cells or tissues in cell and microbial cell culture. A portable bioprocessing bioreactor is a compact, user-friendly device, which is made especially for small space laboratories. The major objective behind the portable bioprocessing bioreactor is the reduction of complex steps involved in conventional bioprocessing bioreactors.

The major factors that drive the growth of the global portable bioprocessing bioreactor market are rapid development of the biopharmaceuticals industry & research areas and increase in demand for high-efficiency bioreactors, less floor space requirement, and technological advancements. However, dearth of skilled professionals and requirement of high maintenance of the device hamper the market growth. Conversely, increase in number of the research laboratories is anticipated to provide lucrative opportunity for market growth.

The report segments the global portable bioprocessing bioreactor market based on capacity, end user, and region. On the basis of capacity, the market is categorized into 110L, 1050L, 50100L, and 100500L. In terms of end user, it is classified into biopharmaceuticals industry, academic institute, and research laboratories. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global portable bioprocessing bioreactor market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Sartorius Stedim Biotech SA, IKA laboratory, Biosan Laboratories, Inc., General Electric Company, BioProcessors Corporation, Integra Companies, Cesco Bioengineering Co., Ltd., and Ariad Pharmaceuticals.

Key Benefits

  • The study provides an in-depth analysis of the global portable bioprocessing bioreactor market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

 Key Market Segments

  • By Capacity
    • 110L
    • 1050L
    • 50100L
    • 100500L
  • By End User
    • Biopharmaceuticals Industry
    • Academic Institute
    • Research Laboratories
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • IKA laboratory
  • Sartorius Stedim Biotech SA
  • General Electric Company
  • BioProcessors Corporation
  • Integra Companies
  • Ariad Pharmaceuticals.
  • Thermo Fisher Scientific Inc.
  • Cesco Bioengineering Co., Ltd.
  • Merck & Co. Inc.
  • Biosan Laboratories, Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: PORTABLE BIOPROCESSING BIOREACTORS MARKET, BY CAPACITY

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Capacity

    • 4.2. 110L

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. 1050L

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. 50100L

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. 100500L

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: PORTABLE BIOPROCESSING BIOREACTORS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Biopharmaceuticals Industry

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Academic Institute

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Research Laboratories

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: PORTABLE BIOPROCESSING BIOREACTORS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Capacity

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Portable Bioprocessing Bioreactors Market

        • 6.2.5.1. Market Size and Forecast, By Capacity
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Portable Bioprocessing Bioreactors Market

        • 6.2.6.1. Market Size and Forecast, By Capacity
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Portable Bioprocessing Bioreactors Market

        • 6.2.7.1. Market Size and Forecast, By Capacity
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Capacity

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Portable Bioprocessing Bioreactors Market

        • 6.3.5.1. Market Size and Forecast, By Capacity
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Portable Bioprocessing Bioreactors Market

        • 6.3.6.1. Market Size and Forecast, By Capacity
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Portable Bioprocessing Bioreactors Market

        • 6.3.7.1. Market Size and Forecast, By Capacity
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Portable Bioprocessing Bioreactors Market

        • 6.3.8.1. Market Size and Forecast, By Capacity
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Portable Bioprocessing Bioreactors Market

        • 6.3.9.1. Market Size and Forecast, By Capacity
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Portable Bioprocessing Bioreactors Market

        • 6.3.10.1. Market Size and Forecast, By Capacity
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Portable Bioprocessing Bioreactors Market

        • 6.3.11.1. Market Size and Forecast, By Capacity
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Capacity

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Portable Bioprocessing Bioreactors Market

        • 6.4.5.1. Market Size and Forecast, By Capacity
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Portable Bioprocessing Bioreactors Market

        • 6.4.6.1. Market Size and Forecast, By Capacity
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Portable Bioprocessing Bioreactors Market

        • 6.4.7.1. Market Size and Forecast, By Capacity
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Portable Bioprocessing Bioreactors Market

        • 6.4.8.1. Market Size and Forecast, By Capacity
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Portable Bioprocessing Bioreactors Market

        • 6.4.9.1. Market Size and Forecast, By Capacity
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Portable Bioprocessing Bioreactors Market

        • 6.4.10.1. Market Size and Forecast, By Capacity
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Portable Bioprocessing Bioreactors Market

        • 6.4.11.1. Market Size and Forecast, By Capacity
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Portable Bioprocessing Bioreactors Market

        • 6.4.12.1. Market Size and Forecast, By Capacity
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Portable Bioprocessing Bioreactors Market

        • 6.4.13.1. Market Size and Forecast, By Capacity
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Capacity

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Portable Bioprocessing Bioreactors Market

        • 6.5.5.1. Market Size and Forecast, By Capacity
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Portable Bioprocessing Bioreactors Market

        • 6.5.6.1. Market Size and Forecast, By Capacity
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Portable Bioprocessing Bioreactors Market

        • 6.5.7.1. Market Size and Forecast, By Capacity
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Portable Bioprocessing Bioreactors Market

        • 6.5.8.1. Market Size and Forecast, By Capacity
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Portable Bioprocessing Bioreactors Market

        • 6.5.9.1. Market Size and Forecast, By Capacity
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Portable Bioprocessing Bioreactors Market

        • 6.5.10.1. Market Size and Forecast, By Capacity
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Merck And Co. Inc.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Thermo Fisher Scientific Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Sartorius Stedim Biotech SA

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. IKA Laboratory

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Biosan Laboratories, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. General Electric Company

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. BioProcessors Corporation

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Integra Companies

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Cesco Bioengineering Co., Ltd.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Ariad Pharmaceuticals.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 110L, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 1050L, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 50100L, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 100500L, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR BIOPHARMACEUTICALS INDUSTRY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR ACADEMIC INSTITUTE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA PORTABLE BIOPROCESSING BIOREACTORS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. U.S. PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 15. U.S. PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. CANADA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 17. CANADA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE PORTABLE BIOPROCESSING BIOREACTORS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. ITALY PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 28. ITALY PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. UK PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 32. UK PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC PORTABLE BIOPROCESSING BIOREACTORS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. CHINA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 41. CHINA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. INDIA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 45. INDIA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA PORTABLE BIOPROCESSING BIOREACTORS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. UAE PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 68. UAE PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA PORTABLE BIOPROCESSING BIOREACTORS, BY CAPACITY, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA PORTABLE BIOPROCESSING BIOREACTORS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. MERCK AND CO. INC.: KEY EXECUTIVES
  • TABLE 74. MERCK AND CO. INC.: COMPANY SNAPSHOT
  • TABLE 75. MERCK AND CO. INC.: OPERATING SEGMENTS
  • TABLE 76. MERCK AND CO. INC.: PRODUCT PORTFOLIO
  • TABLE 77. MERCK AND CO. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 79. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 80. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 81. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 82. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. SARTORIUS STEDIM BIOTECH SA: KEY EXECUTIVES
  • TABLE 84. SARTORIUS STEDIM BIOTECH SA: COMPANY SNAPSHOT
  • TABLE 85. SARTORIUS STEDIM BIOTECH SA: OPERATING SEGMENTS
  • TABLE 86. SARTORIUS STEDIM BIOTECH SA: PRODUCT PORTFOLIO
  • TABLE 87. SARTORIUS STEDIM BIOTECH SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. IKA LABORATORY: KEY EXECUTIVES
  • TABLE 89. IKA LABORATORY: COMPANY SNAPSHOT
  • TABLE 90. IKA LABORATORY: OPERATING SEGMENTS
  • TABLE 91. IKA LABORATORY: PRODUCT PORTFOLIO
  • TABLE 92. IKA LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. BIOSAN LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 94. BIOSAN LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 95. BIOSAN LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 96. BIOSAN LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 97. BIOSAN LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. GENERAL ELECTRIC COMPANY: KEY EXECUTIVES
  • TABLE 99. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • TABLE 100. GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS
  • TABLE 101. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
  • TABLE 102. GENERAL ELECTRIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. BIOPROCESSORS CORPORATION: KEY EXECUTIVES
  • TABLE 104. BIOPROCESSORS CORPORATION: COMPANY SNAPSHOT
  • TABLE 105. BIOPROCESSORS CORPORATION: OPERATING SEGMENTS
  • TABLE 106. BIOPROCESSORS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 107. BIOPROCESSORS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. INTEGRA COMPANIES: KEY EXECUTIVES
  • TABLE 109. INTEGRA COMPANIES: COMPANY SNAPSHOT
  • TABLE 110. INTEGRA COMPANIES: OPERATING SEGMENTS
  • TABLE 111. INTEGRA COMPANIES: PRODUCT PORTFOLIO
  • TABLE 112. INTEGRA COMPANIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. CESCO BIOENGINEERING CO., LTD.: KEY EXECUTIVES
  • TABLE 114. CESCO BIOENGINEERING CO., LTD.: COMPANY SNAPSHOT
  • TABLE 115. CESCO BIOENGINEERING CO., LTD.: OPERATING SEGMENTS
  • TABLE 116. CESCO BIOENGINEERING CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 117. CESCO BIOENGINEERING CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. ARIAD PHARMACEUTICALS.: KEY EXECUTIVES
  • TABLE 119. ARIAD PHARMACEUTICALS.: COMPANY SNAPSHOT
  • TABLE 120. ARIAD PHARMACEUTICALS.: OPERATING SEGMENTS
  • TABLE 121. ARIAD PHARMACEUTICALS.: PRODUCT PORTFOLIO
  • TABLE 122. ARIAD PHARMACEUTICALS.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PORTABLE BIOPROCESSING BIOREACTORS MARKET
  • FIGURE 3. SEGMENTATION PORTABLE BIOPROCESSING BIOREACTORS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PORTABLE BIOPROCESSING BIOREACTORS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPORTABLE BIOPROCESSING BIOREACTORS MARKET
  • FIGURE 11. PORTABLE BIOPROCESSING BIOREACTORS MARKET SEGMENTATION, BY BY CAPACITY
  • FIGURE 12. PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 110L, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 1050L, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 50100L, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR 100500L, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. PORTABLE BIOPROCESSING BIOREACTORS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 17. PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR BIOPHARMACEUTICALS INDUSTRY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR ACADEMIC INSTITUTE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. PORTABLE BIOPROCESSING BIOREACTORS MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: PORTABLE BIOPROCESSING BIOREACTORS MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. MERCK AND CO. INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. MERCK AND CO. INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. MERCK AND CO. INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. SARTORIUS STEDIM BIOTECH SA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. SARTORIUS STEDIM BIOTECH SA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. SARTORIUS STEDIM BIOTECH SA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. IKA LABORATORY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. IKA LABORATORY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. IKA LABORATORY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. BIOSAN LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. BIOSAN LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. BIOSAN LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. GENERAL ELECTRIC COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. GENERAL ELECTRIC COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. GENERAL ELECTRIC COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. BIOPROCESSORS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. BIOPROCESSORS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. BIOPROCESSORS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. INTEGRA COMPANIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. INTEGRA COMPANIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. INTEGRA COMPANIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. CESCO BIOENGINEERING CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. CESCO BIOENGINEERING CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. CESCO BIOENGINEERING CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. ARIAD PHARMACEUTICALS.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. ARIAD PHARMACEUTICALS.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. ARIAD PHARMACEUTICALS.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Portable Bioprocessing Bioreactors Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved